The reason why PMCB is a crowd pleaser to big pharma is that its pancreatic cancer treatment CIAB will outperform Eli Lilly’s option, which failed to maintain goal of survival in recent trial.
You do realize: Gemcitabine is a current front line drug manufactured by Eli Lilly? That when combined with Abraxane is a front line treatment? That Lilly has a anti-PD-L1 drug for PC in CTs? How about a CD73 inhibitor?
So which of these treatments is the Kenny Wonder Treatment going to outperform. Note the last 2 above are in CTs. Where is the Kenny Wonder Treatment? Answer: Nowhere.
There is absolutely no evidence the Kenny Wonder Cure will ever be used as a front line drug. No evidence it has efficacy in a 2nd line setting. Currently little to no evidence it will ever undergo a mythical CT.
No... big pharma isn't waiting for the next Kenny PR pump.
News 
Market Data 
Discover 
